Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial.
Affiliation
Department of Radiotherapy, Christie Hospital, Manchester, UK.Issue Date
1990-01
Metadata
Show full item recordAbstract
Patients with a clinically palpable breast carcinoma, 4 cm or less in diameter, and with no palpable nodes in the axilla were prospectively entered into a randomized clinical trial. A total of 713 patients were registered between November 1982 and December 1987, of whom 708 are evaluable at a median follow-up of 37 months. Following excision of the primary tumour, patients were randomly allocated either to have radiotherapy to the affected quadrant only (LF group) or to the whole breast and regional lymph node areas (WF group). No adjuvant hormone or chemotherapy was prescribed. The primary tumour was reported as completely excised histologically in 80% of cases, incompletely excised in 10%, and no estimate was possible in 10%. At six years from first randomization, 96% of the WF group and 92% of the LF group have remained free of breast recurrence (94% and 87% actuarial breast recurrence-free survival at 5 years). Part of the difference may be explained by the 20% recurrence rate in the breast for lobular carcinomas treated within the LF group. Of the WF group 14 patients (4%) developed recurrent disease in the axilla, compared to 50 patients (14%) in the LF group (95% and 86% actuarial axillary recurrent-free survival at 5 years). Patients with primary tumours histologically 1 cm or less in diameter had a 98% actuarial 5-year survival compared with 74% for those with tumours measuring 2 cm or more in diameter (P = 0.003). Continued follow-up of these patients will provide further information on the factors governing local/regional recurrence.Citation
Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. 1990, 2 (1):27-34 Clin Oncol (R Coll Radiol)Journal
Clinical OncologyDOI
10.1016/S0936-6555(05)80215-8PubMed ID
2261385Type
ArticleLanguage
enISSN
0936-6555ae974a485f413a2113503eed53cd6c53
10.1016/S0936-6555(05)80215-8
Scopus Count
Collections
Related articles
- The Christie Hospital breast conservation trial: an update at 8 years from inception.
- Authors: Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS
- Issue date: 1993
- Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
- Authors: Sávolt Á, Péley G, Polgár C, Udvarhelyi N, Rubovszky G, Kovács E, Győrffy B, Kásler M, Mátrai Z
- Issue date: 2017 Apr
- Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
- Authors: Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M
- Issue date: 1999 Jan 1
- Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
- Authors: Touboul E, Buffat L, Lefranc JP, Blondon J, Deniaud E, Mammar H, Laugier A, Schlienger M
- Issue date: 1996 Mar 15
- Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation.
- Authors: Mignano JE, Zahurak ML, Chakravarthy A, Piantadosi S, Dooley WC, Gage I
- Issue date: 1999 Oct 1